SOUTH SAN FRANCISCO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that AMBER-HFpEF (Assessment of…
– Presented data includes a 97% Calculated Objective Response Rate (ORR) of study subjects following treatment with VP-315 – Posters…
Ms. Colacot brings over 25 years of quality leadership experience across the biopharmaceutical and medical device industriesNEW YORK, Jan. 21,…
ELYXYB®, a rapid onset and ready-to-use formulation of Celecoxib, delivers a first line non-opioid therapeutic alternative to habit-forming opioids and…
VANCOUVER, BC / ACCESS Newswire / January 21, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a…
Supporting Nurses and Essential Workers with Thoughtfully Designed Products That Promote Mental Wellness, Confidence, and Community Connection GREENWICH, CT /…
Scalable, User-Friendly Data Management Solution Offers Innovation, Integration, and Transparency for Pharma Operations. SOFIA, BG / ACCESS Newswire / January…
Sapphire Pharma Chairman & CEO Ramu Veerappan to Speak at World Economic Forum 2025Davos, Switzerland--(Newsfile Corp. - January 19, 2025)…
WEST PALM BEACH, FL / ACCESS Newswire / January 20, 2025 / Ethema Health Corporation (OTCPINK:GRST) ("Ethema" "GRST" or the…
SHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…